Latest News.

12.13.2011
Aestus Therapeutics reports positive results in
Phase II neuropathic pain trial for treatment of
post-­‐herpetic neuralgia

9.19.2011
Aestus Therapeutics and Prosidion Ltd Sign License Agreement for Novel Chronic Pain
Therapeutic

9.19.2011
ALS Therapy Development Institute and Aestus Therapeutics, Inc., expand Collaboration on Development of Novel ALS Therapies

2.23.2011
Aestus Aestus Therapeutics Initiates Phase 2 Clinical Trial for Novel Neuropathic Pain Treatment

11.3.2010
Aestus Therapeutics Awarded Qualifying Therapeutic Development Project Grant for Clinical Studies of Novel Pain Treatment

11.1.2010
Aestus Therapeutics, Inc. featured in NJ Entrepreneur

7.14.2010
Aestus Therapeutics Signs Agreement with Eisai to Develop Novel Treatments for Psychiatric Disorders

6.28.2010
Aestus Therapeutics and Astellas Pharma Sign License Deal for Novel Chronic Pain Therapeutic